Funded Startups in Bala Cynwyd
The largest disclosed round in Bala Cynwyd among the most recent five entries is Larimar Therapeutics’ $100M on 2026-02-25, which dwarfs the next-largest d…
The largest disclosed round in Bala Cynwyd among the most recent five entries is Larimar Therapeutics’ $100M on 2026-02-25, which dwarfs the next-largest disclosed amount of $10M (SwanBio Therapeutics on 2023-10-04) and sits far above the remaining disclosed rounds ($5M Guardinex on 2021-11-10, $3M LoveMyDelta on 2023-06-06). Date-wise, the list clusters around 2023 with three disclosed financings in quick succession (LoveMyDelta 2023-06-06 for $3M; SwanBio 2023-10-04 for $10M; plus the earlier most recent $100M in 2026), while the oldest disclosed round shown is Guardinex’s $5M on 2021-11-10. Sector and label mix also stand out: biotechnology appears in 2 of 5 companies (Larimar Therapeutics, SwanBio Therapeutics) and Artificial Intelligence shows up once (LoveMyDelta). Four of the five companies have a “Series Unknown” classification (Larimar Therapeutics, Alex’s Lemonade Stand Foundation, SwanBio Therapeutics, LoveMyDelta), and one is labeled “Series A” (Guardinex).
Most recent rounds
5 shownRelated listings
Frequently asked
What is the largest disclosed round shown for Bala Cynwyd, and how does it compare with the other disclosed amounts?
Larimar Therapeutics raised $100M on 2026-02-25, and that disclosed figure is substantially above the next-largest disclosed amount of $10M (SwanBio Therapeutics on 2023-10-04). The remaining disclosed rounds cluster at $5M (Guardinex, 2021-11-10) and $3M (LoveMyDelta, 2023-06-06), with Alex’s Lemonade Stand Foundation listed as undisclosed on 2025-08-12.
Do the most recent rounds cluster in time within this Bala Cynwyd subset?
Yes for 2023: two disclosed financings fall within four months of each other—LoveMyDelta closed on 2023-06-06 for $3M and SwanBio Therapeutics on 2023-10-04 for $10M. Beyond that, the timeline spans 2021-11-10 (Guardinex, $5M) through 2026-02-25 (Larimar Therapeutics, $100M).
Are any sectors over-represented compared to the rest of the list?
Biotechnology accounts for 2 of the 5 companies (Larimar Therapeutics and SwanBio Therapeutics), making it the only sector appearing more than once. The other categories appear once each: Health Care (Alex’s Lemonade Stand Foundation), Artificial Intelligence (LoveMyDelta), and Financial Services (Guardinex).
How dominated is the stage labeling, and does it affect how you interpret the biggest rounds?
“Series Unknown” covers 4 of the 5 companies (Larimar Therapeutics, Alex’s Lemonade Stand Foundation, SwanBio Therapeutics, LoveMyDelta). Only Guardinex is labeled “Series A” (2021-11-10, $5M), so the largest disclosed round ($100M on 2026-02-25) sits under “Series Unknown,” not a named stage.
Are there outliers in disclosed amount or disclosure status that a diligence reviewer should flag?
Larimar Therapeutics at $100M (2026-02-25) is a clear amount outlier versus the rest of the disclosed rounds ($10M, $5M, $3M). Separately, Alex’s Lemonade Stand Foundation is an information outlier on disclosure itself: it is dated 2025-08-12 but listed with an undisclosed amount.
Know which startups just got funded. Every week.
Fresh funding rounds, new companies, and the sectors moving fastest — in your inbox every Monday morning.
Free. Sent every Monday. Unsubscribe anytime.